Clinical Trial: Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction

U.S., June 10 -- ClinicalTrials.gov registry received information related to the study (NCT07634640) titled 'Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction' on June 04.

Brief Summary: Subjects undergo a gadolinium-based CMR followed by an iron infusion and then a repeat CMR in 72 hours

Study Start Date: Nov. 03, 2023

Study Type: INTERVENTIONAL

Condition: Heart Failure With Preserved Ejection Fraction (HFPEF)

Intervention: DRUG: Ferumoxytol infusion

Ferumoxytol infusion followed by cardiac MRI

Recruitment Status: RECRUITING

Sponsor: University of Florida

Published by HT Digital Content Services with permission from Health Daily Digest....